drugset / Trial / NCT00356135

Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clopidogrel After a Cardiac Event

NCT00356135 ↗

Phase 2 Completed 139 enrolled Eli Lilly and Company Daiichi Sankyo · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will compare the effect of a prasugrel 10-mg maintenance dose with a clopidogrel 75-mg maintenance dose on platelet activity, approximately 1 week after the first dose of study drug, in subjects who have been taking clopidogrel 75 mg daily following a percutaneous coronary intervention (PCI) with placement of a stent, performed to treat acute coronary syndrome (ACS).

Timeline

Start
2006-07
Primary completion
2008-12
Completion
2008-12

Outcome

Met primary endpoint

paper at 1 week (primary end point) was lower after prasugrel MD compared with clopidogrel MD (41.1% vs. 55.0%, p < 0.0001) PMID 20846599 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Clopidogrel Small molecule 75 mg Oral
Subject Prasugrel Small molecule 10 mg Oral